Article
2023 Pharma Predictions
Ravi Samavedam
In this Pharma Manufacturing article, you will gain insight into industry predictions of life science leaders for 2023.
“Bridge facilities are becoming a cost-effective way for pharma manufacturers to scale their operations to meet demand without building facilities that may remain largely vacant.”
- Ravi Samavedam, Chief Innovation Officer at Azzur Group
Read the full article published on Pharma Manufacturing's website and featured in their January/February magazine issue or learn more about the unique hybrid model, Azzur Cleanrooms on Demand™, that is accommodating the growing demand in the biomanufacturing market.
Ravi Samavedam
Ravi Samavedam joined Azzur Group in 2012 and is a Biochemical Engineer with more than 20 years of experience. Prior to his appointment to Chief Innovation Officer (CINO), Ravi served as President of Azzur Cleanrooms on Demand™ and previously was a General Manager of Azzur Boston. Ravi has been a part of technical operations, quality, and validation departments at some of the world’s foremost pharmaceutical manufacturers. He is an expert in phase-appropriate cGMP implementation, process validation, supplier management, and technology transfer. Ravi is an active member of industry and peer groups, and he is a frequent speaker at industry events.
Connect On Linkedin